Enoxaparin Sodium EMA
approved Biosimilar
Inhixa is an Anticoagulant LMWHs (low molecular weight Heparins)
Used for Treatment and prophylaxis of DVT (Deep Vein thrombosis)
with or without PE (Pulmonary Embolism) and many other approved
indications.
Inhixa is used currently to treat patients across the country in both
private and Governmental Hospitals
Available in following concentrations (100 ,80 ,60 ,40 ,20) mgs,
as packs of 2s PFS (Prefilled Syringes)